Palvella Therapeutics (PVLA) Leases: 2019-2023
Historic Leases for Palvella Therapeutics (PVLA) over the last 3 years, with Jun 2023 value amounting to $3.8 million.
- Palvella Therapeutics' Leases rose 5.50% to $3.8 million in Q2 2023 from the same period last year, while for Jun 2023 it was $3.8 million, marking a year-over-year increase of 5.50%. This contributed to the annual value of $3.7 million for FY2022, which is 5.22% down from last year.
- Latest data reveals that Palvella Therapeutics reported Leases of $3.8 million as of Q2 2023, which was up 0.53% from $3.8 million recorded in Q1 2023.
- In the past 5 years, Palvella Therapeutics' Leases registered a high of $4.0 million during Q3 2021, and its lowest value of $3.2 million during Q1 2020.
- Moreover, its 3-year median value for Leases was $3.8 million (2023), whereas its average is $3.8 million.
- In the last 5 years, Palvella Therapeutics' Leases increased by 19.53% in 2021 and then decreased by 14.47% in 2022.
- Quarterly analysis of 5 years shows Palvella Therapeutics' Leases stood at $3.4 million in 2019, then climbed by 14.49% to $3.9 million in 2020, then fell by 0.64% to $3.9 million in 2021, then dropped by 5.22% to $3.7 million in 2022, then rose by 5.50% to $3.8 million in 2023.
- Its Leases stands at $3.8 million for Q2 2023, versus $3.8 million for Q1 2023 and $3.7 million for Q4 2022.